Most medical device companies begin with an engineer's concept and then search for a clinical problem to solve. RC Medical, a medical device venture studio based in Lake Forest, California, reverses that process by starting in the interventional suite, where physicians identify unmet needs weekly. "We go to the interventional suite first," said David Ferrera, CEO of RC Medical. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing." This physician-first approach is central to the studio's model and carries significant implications for how devices for interventional radiology are conceived and brought to market.
Rather than performing contract work for outside clients, RC Medical partners directly with physician-entrepreneurs to uncover new technology and new indications for devices. When an idea clears an early evaluation, the studio forms a standalone company around it, providing funding, engineering, regulatory guidance, and business structure. This differs from the traditional approach of folding new ideas into an existing product line, which can cause promising concepts to be lost in a larger portfolio. "Each idea gets its own company, its own team, its own focus," Ferrera said. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to." The model has already produced three separate companies: Single Pass, Infinity Neuro, and Sonorous NV, each originating from a specific clinical problem described by a physician.
Ferrera's nearly three decades of experience in interventional neuroradiology and related fields, including co-founding Blockade Medical and serving as Chief Technology Officer of Balt Global, inform the studio's structure. He emphasizes that physicians in these procedures encounter problems that never appear on a traditional product roadmap. "A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he said. "That detail doesn't show up unless you're building with the physician, not for them." By capturing those details early, before a device design is finalized, the studio model may reduce the risk of costly revisions and improve the likelihood of clinical adoption.
The implications extend beyond individual devices. For interventional radiologists, the model offers a direct route to turn clinical insights into tangible products, with the physician remaining involved throughout development and commercialization. For the broader medical device industry, it represents a shift toward demand-driven innovation, where clinical need dictates design rather than the reverse. Ferrera acknowledges that not every idea warrants a new company. "Some ideas are better as a feature of an existing product, not a new company," he said. "Part of the first conversation is being honest about which one this is." That candor helps ensure resources are directed toward the most viable concepts.
As interventional radiology continues to evolve, RC Medical's venture studio model could serve as a blueprint for aligning engineering and clinical expertise. By keeping physicians at the center of the process and giving each promising idea its own dedicated company, the studio aims to accelerate the translation of clinical insights into market-ready devices, ultimately benefiting patient care.
